1. Home
  2. PSTV vs WYY Comparison

PSTV vs WYY Comparison

Compare PSTV & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • WYY
  • Stock Information
  • Founded
  • PSTV 1996
  • WYY 1991
  • Country
  • PSTV United States
  • WYY United States
  • Employees
  • PSTV N/A
  • WYY N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • WYY EDP Services
  • Sector
  • PSTV Health Care
  • WYY Technology
  • Exchange
  • PSTV Nasdaq
  • WYY Nasdaq
  • Market Cap
  • PSTV 61.1M
  • WYY 48.9M
  • IPO Year
  • PSTV N/A
  • WYY 1998
  • Fundamental
  • Price
  • PSTV $0.51
  • WYY $7.03
  • Analyst Decision
  • PSTV Strong Buy
  • WYY Strong Buy
  • Analyst Count
  • PSTV 4
  • WYY 3
  • Target Price
  • PSTV $7.75
  • WYY $8.67
  • AVG Volume (30 Days)
  • PSTV 9.7M
  • WYY 72.9K
  • Earning Date
  • PSTV 10-30-2025
  • WYY 11-13-2025
  • Dividend Yield
  • PSTV N/A
  • WYY N/A
  • EPS Growth
  • PSTV N/A
  • WYY N/A
  • EPS
  • PSTV N/A
  • WYY N/A
  • Revenue
  • PSTV $5,258,000.00
  • WYY $144,421,640.00
  • Revenue This Year
  • PSTV $9.91
  • WYY $9.19
  • Revenue Next Year
  • PSTV $1.06
  • WYY $13.16
  • P/E Ratio
  • PSTV N/A
  • WYY N/A
  • Revenue Growth
  • PSTV N/A
  • WYY 16.25
  • 52 Week Low
  • PSTV $0.16
  • WYY $2.19
  • 52 Week High
  • PSTV $2.31
  • WYY $7.55
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 40.47
  • WYY 67.37
  • Support Level
  • PSTV $0.49
  • WYY $6.20
  • Resistance Level
  • PSTV $0.55
  • WYY $7.55
  • Average True Range (ATR)
  • PSTV 0.05
  • WYY 0.49
  • MACD
  • PSTV -0.02
  • WYY 0.04
  • Stochastic Oscillator
  • PSTV 10.97
  • WYY 81.74

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: